Initiated Neutral X

MRNA Moderna

Citigroup

$40

Downgrades Overweight Eq Weight X

MRNA Moderna

Barclays

$111 $45

Downgrades Buy Neutral X

MRNA Moderna

Goldman

$99 $51

Resumed Underperform X

MRNA Moderna

BofA Securities

$41

Initiated Hold X

MRNA Moderna

Berenberg

$42

Upgrades Hold Buy X

MRNA Moderna

HSBC Securities

$58

Initiated Underperform X

MRNA Moderna

Wolfe Research

$40

Initiated Mkt Perform X

MRNA Moderna

Bernstein

$55

Downgrades Buy Hold X

MRNA Moderna

Jefferies

$120 $65

Downgrades Neutral Underweight X

MRNA Moderna

JP Morgan

$88 $70

Downgrades Outperform Perform X

MRNA Moderna

Oppenheimer

Upgrades Reduce Hold X

MRNA Moderna

HSBC Securities

$82

Upgrades Sell Hold X

MRNA Moderna

Deutsche Bank

$85 $80

Downgrades Outperform Sec Perform X

MRNA Moderna

RBC Capital Mkts

$125 $90

Downgrades Hold Reduce X

MRNA Moderna

HSBC Securities

$75 $86

Upgrades Perform Outperform X

MRNA Moderna

Oppenheimer

$142

Initiated Hold X

MRNA Moderna

Canaccord Genuity

$82

Upgrades Reduce Hold X

MRNA Moderna

HSBC Securities

$89 $69

Downgrades Hold Sell X

MRNA Moderna

Deutsche Bank

$125 $60

Downgrades Outperform Mkt Perform X

MRNA Moderna

TD Cowen

$145 $125

Downgrades Buy Hold X

MRNA Moderna

Deutsche Bank

$125

Initiated Mkt Perform X

MRNA Moderna

William Blair

$136.28

Initiated Reduce X

MRNA Moderna

HSBC Securities

$97

Upgrades Neutral Buy X

MRNA Moderna

UBS

$221 $191

Initiated Neutral X

MRNA Moderna

Guggenheim

Upgrades Mkt Perform Outperform X

MRNA Moderna

TD Cowen

$150 $180

Initiated Outperform X

MRNA Moderna

RBC Capital Mkts

$200

Downgrades Mkt Perform Underperform X

MRNA Moderna

SVB Securities

$111 $93

Upgrades Hold Buy X

MRNA Moderna

Jefferies

$170 $275

Downgrades Buy Neutral X

MRNA Moderna

Chardan Capital Markets

$186 $191

Upgrades Underperform Mkt Perform X

MRNA Moderna

SVB Leerink

$174 $101

Upgrades Hold Buy X

MRNA Moderna

Deutsche Bank

$165

Upgrades Sell Neutral X

MRNA Moderna

Redburn

Upgrades Sell Hold X

MRNA Moderna

Deutsche Bank

$175

Upgrades Underperform Neutral X

MRNA Moderna

BofA Securities

$135 $180

Initiated Neutral X

MRNA Moderna

UBS

$221

Initiated Market Perform X

MRNA Moderna

Cowen

Initiated Outperform X

MRNA Moderna

Wolfe Research

$304

Initiated Sell X

MRNA Moderna

Deutsche Bank

$250

Upgrades Neutral Overweight X

MRNA Moderna

Piper Sandler

$445

Reiterated Hold X

MRNA Moderna

Jefferies

$170 $250

Downgrades Neutral Underperform X

MRNA Moderna

BofA Securities

Initiated Buy X

MRNA Moderna

Chardan Capital Markets

$40

Initiated Overweight X

MRNA Moderna

Barclays

$20

Initiated Buy X

MRNA Moderna

BofA/Merrill

$20

Initiated Buy X

MRNA Moderna

Goldman

$25

Initiated Overweight X

MRNA Moderna

JP Morgan

$22

Initiated Overweight X

MRNA Moderna

Morgan Stanley

$29

Initiated Buy X

MRNA Moderna

Needham

$28

Initiated Overweight X

MRNA Moderna

Piper Jaffray

$24

MRNA  Moderna, Inc.

Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.